ABOzymes Biomedical Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • ABOzymes Biomedical's estimated annual revenue is currently $1.3M per year.(i)
  • ABOzymes Biomedical's estimated revenue per employee is $77,500

Employee Data

  • ABOzymes Biomedical has 17 Employees.(i)
  • ABOzymes Biomedical grew their employee count by -15% last year.

ABOzymes Biomedical's People

NameTitleEmail/Phone
1
VP, Product DevelopmentReveal Email/Phone
2
Chief Medical OfficerReveal Email/Phone
3
President & CEOReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.1M4018%$40MN/A
#2
$0.2M20%N/AN/A
#3
$1.3M17-15%N/AN/A
#4
$2.6M176%N/AN/A
#5
$12.9M835%N/AN/A
#6
$1.9M244%$89.5MN/A
#7
$2.8M186%N/AN/A
#8
$40.3M26021%N/AN/A
#9
$0.9M60%N/AN/A
#10
$0.6M4-20%N/AN/A
Add Company

What Is ABOzymes Biomedical?

ABOzymes Biomedical Inc. (“ABOzymes”) is an early-stage enterprise with an innovative, unique, and proprietary platform that enables a world where a person’s blood type is no longer the first constraint when patients need life-saving organ transplants or blood transfusions. ABOzymes’ first product, ABOperfusion-A, is an additive to existing organ preservation solutions. The enzymes prime and then eliminate the marker on cells that determines blood group A rendering it group O, the universal donor type. By converting group A organs for transplantation to group O organs, our technology will enable more organ matching opportunities, optimize allocation, ensure more equitable distribution of donor organs and ultimately reduce the waiting list times of patients waiting for a life saving transplant procedure.

keywords:N/A

N/A

Total Funding

17

Number of Employees

$1.3M

Revenue (est)

-15%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.5M17N/AN/A
#2
$2.1M17N/AN/A
#3
$2.1M17N/AN/A
#4
$1.5M1742%N/A
#5
$3.5M17-35%N/A